TickerFactsScreenerDevelopers

Indivior Pharmaceuticals, Inc. (INDV) — Cost of Revenue

Annual figures by fiscal year, from SEC filings.

2022: $151.00M2023: $174.00M2024: $231.00M2025: $246.00M$246.00M
2022Cost of Revenue (USD)2025
Fiscal YearCost of RevenueChange YoY
2025$246.00M+6.5%
2024$231.00M+32.8%
2023$174.00M+15.2%
2022$151.00M—